These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9855597)

  • 1. Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae.
    Wiener-Megnagi Z; Ben-Shlomo I; Goldberg Y; Shalev E
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1565-7. PubMed ID: 9855597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of selected thrombophilias in women with placental abruption.
    Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden in pregnancies complicated by placental abruption.
    Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
    BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women.
    Jääskeläinen E; Toivonen S; Romppanen EL; Helisalmi S; Keski-Nisula L; Punnonen K; Heinonen S
    Placenta; 2004; 25(8-9):730-4. PubMed ID: 15450391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombophilic mutation by women with serious pregnancy complications].
    Vavrinková B; Binder T; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Apr; 77(2):171-4. PubMed ID: 22702078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of genetic thrombophilia in women with complications of pregnancy.
    Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB
    N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
    Dudding TE; Attia J
    Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden in pregnancies complicated by placental abruption.
    Facchinetti F
    BJOG; 2004 Jan; 111(1):93; author reply 93-4. PubMed ID: 14687065
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of the factor V Leiden mutation on pregnancy.
    Spina V; Aleandri V; Morini F
    Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science?
    Larciprete G; Rossi F; Deaibess T; Brienza L; Barbati G; Romanini E; Gioia S; Cirese E
    J Obstet Gynaecol Res; 2010 Oct; 36(5):996-1002. PubMed ID: 20868443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic mutations are a main risk factor for placental abruption.
    Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C
    Haematologica; 2003 Jul; 88(7):785-8. PubMed ID: 12857557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss.
    Kupferminc MJ; Peri H; Zwang E; Yaron Y; Wolman I; Eldor A
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):963-7. PubMed ID: 11081681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.